131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission

In an attempt to improve outcomes for patients with acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT), we conducted a phase 1/2 study in which targeted irradiation delivered by (131)I–anti-CD45 antibody was combined with targeted busulfan (BU; area-under-curve, 6...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Pagel, John M., Appelbaum, Frederick R., Eary, Janet F., Rajendran, Joseph, Fisher, Darrell R., Gooley, Ted, Ruffner, Katherine, Nemecek, Eneida, Sickle, Eileen, Durack, Larry, Carreras, Jeanette, Horowitz, Mary M., Press, Oliver W., Gopal, Ajay K., Martin, Paul J., Bernstein, Irwin D., Matthews, Dana C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: © 2006 by The American Society of Hematology 2006
Onderwerpen:
Transplantation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895719/
https://ncbi.nlm.nih.gov/pubmed/16254140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-06-2317
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items